All Stories

Quest Diagnostics to claim Fresenius Medical Care’s kidney dialysis testing portfolio

The assets from Fresenius’ Spectra Laboratories subsidiary include water purification testing for use in dialysis machines, a new area for Quest.

Feb 26, 2025 - 18:25
 0
Quest Diagnostics to claim Fresenius Medical Care’s kidney dialysis testing portfolio
The assets from Fresenius’ Spectra Laboratories subsidiary include water purification testing for use in dialysis machines, a new area for Quest.
Read More

Tags:

Previous Article

Schwarzenegger spins ‘Terminator’ catchphrase for Zimmer Biomet’s big marketing ...

Next Article

Multimodal Computational Framework Can Predict Prognosis of Myelodysplastic Synd...

Related Posts

Tris' next-gen pain drug completes trio of clinical wins, setting up push to FDA

Tris' next-gen pain drug completes trio of clinical win...

Mar 6, 2025  0

Atsena raises $150M for ocular gene therapies with Bain, Sofinnova in tow

Atsena raises $150M for ocular gene therapies with Bain...

Apr 2, 2025  0

Illumina board adds activist investor, elevates Scott Gottlieb to chair

Illumina board adds activist investor, elevates Scott G...

Mar 27, 2025  0